NCT00430066View on ClinicalTrials.gov

Effects of Imatinib Mesylate in Polycythemia Vera

PHASE2CompletedINTERVENTIONAL

Enrollment

9

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

September 30, 2012

Conditions

Polycythemia Vera

Interventions

DRUG

Imatinib Mesylate

400 mg/die for 6 months

All Listed Sponsors

lead

Niguarda Hospital

OTHER

NCT00430066 - Effects of Imatinib Mesylate in Polycythemia Vera | Biotech Hunter | Biotech Hunter